TickerGuard
Buy Day today: Poor (44) Weak market breadth · today: Core PCE (August) ≈
ETON

Eton Pharmaceuticals Inc

Healthcare · Drug Manufacturers - Specialty & Generic

55.60$ -2.6% vs. previous close Closing price · As of: Sep 23, 2026

Statements

Income Statement

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Income Statement ETON
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
– – – -95.9% +55,879.5% -2.7% +48.9% +23.3% +104.9%
– +384.6% +619.0% -36.9% +817.1% +164.3% +52.6% +47.4% +138.5%
– – – -148.8% – -25.5% +47.1% +11.2% +82.6%
– +43.2% +105.3% +22.1% -55.8% -35.9% -16.9% -2.0% +138.6%
– -2.8% +60.9% +69.0% +13.4% +28.4% +1.9% +20.2% +57.4%
– +44.6% +85.1% +40.6% -22.9% +9.1% -1.4% +16.9% +64.1%
– – – – – – – – –
– – +71.3% +216.4% +17.2% -8.3% +11.0% +89.2% +138.5%
– – – – – – – – –
– – – – +17.1% -24.4% -67.5% -93.9% +186.7%
– – – – – – – – –
– – – – – – – -409.9% –

Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?